Skip to content
Disclosery

Data Collective IV GP, LLC

Follow

13F filer, CIK 1664974, PALO ALTO, CA

Data Collective IV GP, LLC reported $58,507,268 across 3 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-26-015677

Period
2025-12-31
Reported value
$58.5M
Holdings
3
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
EVLVreduced-410,000-$2.94M
ROIVexited-3,875-$58.6K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001104659-26-015677, largest first. % of portfolio is the value over $58,507,268, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EVLVEVOLV TECHNOLOGIES HLDNGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,681,281 shares; 2024Q4: 9,681,281 shares; 2025Q1: 9,681,281 shares; 2025Q2: 9,681,281 shares; 2025Q3: 5,000,000 shares; 2025Q4: 4,590,000 shares 4,590,000$32.9M56.17%-410,000Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,941,120 shares; 2024Q4: 5,941,120 shares; 2025Q1: 5,941,120 shares; 2025Q2: 5,941,120 shares; 2025Q3: 5,941,120 shares; 2025Q4: 5,941,120 shares 5,941,120$24.3M41.53%0Timeline
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 100,350 shares; 2024Q4: 100,350 shares; 2025Q1: 100,350 shares; 2025Q2: 100,350 shares; 2025Q3: 100,350 shares; 2025Q4: 100,350 shares 100,350$1.34M2.3%0

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ROIVROIVANT SCIENCES LTD3,875$58.6Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-015677 base2026-02-17acceptance time not in the bulk data set